Huntington National Bank Buys 161 Shares of CME Group Inc. (NASDAQ:CME)

Huntington National Bank boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 5.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,399 shares of the financial services provider’s stock after acquiring an additional 161 shares during the period. Huntington National Bank’s holdings in CME Group were worth $750,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CME. Plato Investment Management Ltd boosted its holdings in CME Group by 2.5% during the third quarter. Plato Investment Management Ltd now owns 15,390 shares of the financial services provider’s stock valued at $3,392,000 after purchasing an additional 379 shares in the last quarter. Pinnacle Financial Partners Inc lifted its position in shares of CME Group by 2.0% during the 3rd quarter. Pinnacle Financial Partners Inc now owns 100,159 shares of the financial services provider’s stock worth $22,100,000 after buying an additional 1,925 shares during the period. Aptus Capital Advisors LLC lifted its position in shares of CME Group by 4.2% during the 3rd quarter. Aptus Capital Advisors LLC now owns 3,007 shares of the financial services provider’s stock worth $663,000 after buying an additional 121 shares during the period. Commonwealth Retirement Investments LLC boosted its stake in CME Group by 2.5% in the 3rd quarter. Commonwealth Retirement Investments LLC now owns 10,439 shares of the financial services provider’s stock valued at $2,303,000 after buying an additional 255 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. grew its position in CME Group by 0.9% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 958,085 shares of the financial services provider’s stock valued at $211,401,000 after acquiring an additional 8,561 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

CME has been the subject of a number of analyst reports. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a report on Thursday, October 24th. Bank of America boosted their price target on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Redburn Atlantic cut shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a research note on Tuesday, October 8th. Finally, Barclays increased their price target on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $224.47.

Insider Activity

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 5.38 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock worth $3,441,063 over the last quarter. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $225.28 on Friday. The firm’s 50 day simple moving average is $222.62 and its 200 day simple moving average is $210.37. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a market capitalization of $81.12 billion, a price-to-earnings ratio of 23.69, a P/E/G ratio of 5.26 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the business posted $2.25 earnings per share. As a group, sell-side analysts forecast that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is currently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.